Tian-Chen Xiong

459 total citations
10 papers, 357 citations indexed

About

Tian-Chen Xiong is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Tian-Chen Xiong has authored 10 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 2 papers in Infectious Diseases. Recurrent topics in Tian-Chen Xiong's work include interferon and immune responses (5 papers), Immune Cell Function and Interaction (3 papers) and RNA modifications and cancer (2 papers). Tian-Chen Xiong is often cited by papers focused on interferon and immune responses (5 papers), Immune Cell Function and Interaction (3 papers) and RNA modifications and cancer (2 papers). Tian-Chen Xiong collaborates with scholars based in China, United States and France. Tian-Chen Xiong's co-authors include Bo Zhong, Dandan Lin, Qiang Zhang, Zhidong Zhang, Tianzi Liuyu, He Sun, Jing Yao, Hong‐Bing Shu, Haiying Wang and Qiyun Zhu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Tian-Chen Xiong

10 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tian-Chen Xiong China 6 235 213 81 64 55 10 357
Meng‐Xin Zhang China 6 251 1.1× 244 1.1× 76 0.9× 72 1.1× 60 1.1× 10 396
Tianzi Liuyu China 9 289 1.2× 298 1.4× 78 1.0× 73 1.1× 71 1.3× 9 446
Claudia Gürtler Germany 5 226 1.0× 194 0.9× 55 0.7× 54 0.8× 37 0.7× 6 368
Christian Urban Germany 8 170 0.7× 176 0.8× 56 0.7× 65 1.0× 46 0.8× 15 342
Li Zhong China 8 216 0.9× 203 1.0× 63 0.8× 40 0.6× 55 1.0× 15 323
Swarupa Panda Sweden 6 247 1.1× 215 1.0× 60 0.7× 38 0.6× 48 0.9× 7 354
Roli Mandhana United States 6 225 1.0× 156 0.7× 57 0.7× 53 0.8× 103 1.9× 7 383
Daniel Eng Thiam Teo Singapore 5 226 1.0× 403 1.9× 37 0.5× 47 0.7× 65 1.2× 6 475
Qingcai Meng China 6 362 1.5× 327 1.5× 79 1.0× 140 2.2× 58 1.1× 7 546
A. V. Kubarenko Germany 8 264 1.1× 263 1.2× 60 0.7× 48 0.8× 25 0.5× 11 421

Countries citing papers authored by Tian-Chen Xiong

Since Specialization
Citations

This map shows the geographic impact of Tian-Chen Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tian-Chen Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tian-Chen Xiong more than expected).

Fields of papers citing papers by Tian-Chen Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tian-Chen Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tian-Chen Xiong. The network helps show where Tian-Chen Xiong may publish in the future.

Co-authorship network of co-authors of Tian-Chen Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Tian-Chen Xiong. A scholar is included among the top collaborators of Tian-Chen Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tian-Chen Xiong. Tian-Chen Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Jiang, Yun, Tian-Chen Xiong, Yiliang Fang, et al.. (2025). Enhanced FOS expression improves tumor clearance and resists exhaustion in NR4A3-deficient CAR T cells under chronic antigen exposure. Science Advances. 11(42). eadw3571–eadw3571. 1 indexed citations
2.
Xiong, Tian-Chen, Ge Wang, Peng Yu, et al.. (2025). CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors. Journal of Clinical Investigation. 135(15). 1 indexed citations
3.
Li, Fangxu, Yanhong Wei, Qianhui Zhang, et al.. (2024). Disulfiram ameliorates STING/MITA-dependent inflammation and autoimmunity by targeting RNF115. Cellular and Molecular Immunology. 21(3). 275–291. 12 indexed citations
4.
Yang, Ruiqi, et al.. (2024). Rapid isolation of pan-neutralizing antibodies against Omicron variants from convalescent individuals infected with SARS-CoV-2. Frontiers in Immunology. 15. 1374913–1374913. 6 indexed citations
5.
Xiong, Tian-Chen, et al.. (2023). The Rise of New Media: A Benefit or a Threat to Traditional Media-Based Society?. Lecture Notes in Education Psychology and Public Media. 4(1). 1060–1065. 1 indexed citations
6.
Xiong, Tian-Chen, Fangxu Li, Zhen Tang, et al.. (2022). The E3 ubiquitin ligase ARIH1 promotes antiviral immunity and autoimmunity by inducing mono-ISGylation and oligomerization of cGAS. Nature Communications. 13(1). 5973–5973. 42 indexed citations
7.
Liu, Qiang, Chang Xie, Xin Wei, et al.. (2021). The industrial solvent 1,4-Dioxane causes hyperalgesia by targeting capsaicin receptor TRPV1. DRYAD. 5 indexed citations
8.
Zhang, Meng‐Xin, Zhen Tang, Qiang Zhang, et al.. (2020). USP22 promotes IRF3 nuclear translocation and antiviral responses by deubiquitinating the importin protein KPNA2. The Journal of Experimental Medicine. 217(5). 61 indexed citations
9.
Xiong, Tian-Chen, et al.. (2020). RNF115 plays dual roles in innate antiviral responses by catalyzing distinct ubiquitination of MAVS and MITA. Nature Communications. 11(1). 5536–5536. 67 indexed citations
10.
Sun, He, Qiang Zhang, Yingying Jing, et al.. (2017). USP13 negatively regulates antiviral responses by deubiquitinating STING. Nature Communications. 8(1). 15534–15534. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026